EW vs NBBK · P/E 47, rev $1.39B vs P/E 14, $863.3M cap
Edwards Lifesciences Corp (EW) versus NB Bancorp, Inc. Common Stock (NBBK) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
NB Bancorp, Inc. Common Stock (NBBK) is a banks - regional company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
NBBK does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NBBK currently screens at market cap $863.3M and trailing P/E 14.4.
Not investment advice. Open the EW and NBBK stock pages for the full models.
Not investment advice.